newsfilter
← Latest News
Business Wire·

Vifor Pharma to revise DIAMOND study, readout expected in H2 2021

COVID-19 pandemic significantly impacted the DIAMOND study, leading to lower-than-anticipated enrolment and slower incidence of cardio-vascular events Independent study Executive Committee recommended new clinically relevant endpoints Data ar